CN Patent

CN1812977A — 取代羧酸

Assigned to Institute for Pharmaceutical Discovery Inc · Expires 2006-08-02 · 20y expired

What this patent protects

本发明涉及式(I)的化合物及其药学上可接受的盐：其可用于治疗胰岛素抵抗或高血糖相关的代谢紊乱症。这些化合物包括蛋白酪氨酸磷酸酶(PTP－1B)的抑制剂，其可用于治疗糖尿病和其它PTB－1B介导的疾病。本发明的化合物也可用于治疗上述疾病的药学组合物和方法中。

USPTO Abstract

本发明涉及式(I)的化合物及其药学上可接受的盐：其可用于治疗胰岛素抵抗或高血糖相关的代谢紊乱症。这些化合物包括蛋白酪氨酸磷酸酶(PTP－1B)的抑制剂，其可用于治疗糖尿病和其它PTB－1B介导的疾病。本发明的化合物也可用于治疗上述疾病的药学组合物和方法中。

Drugs covered by this patent

Patent Metadata

Patent number
CN1812977A
Jurisdiction
CN
Classification
—
Expires
2006-08-02
Drug substance claim
No
Drug product claim
No
Assignee
Institute for Pharmaceutical Discovery Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.